SGMO

#3170
Sangamo Therapeutics, Inc. Common Stock
0.43
-4.44%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
0.43
0.43
Intervallo Annuale
0.35
1.07
Variazione giornaliera
-4.44%
Variazione Mensile
+13.16%
Variazione di 6 mesi
-20.37%
Variazione Annuale
-56.12%
Chiusura Precedente
0.45
Open
0.43
Bid
Ask
Low
0.43
High
0.43
Volume
17
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 130.85 M
  • Employee 183
  • Founded 1995
  • CEO Sandy Macrae
  • Website www.sangamo.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHYT80
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.68
Price to sales ratio
4.82
Dividends per share
—
Dividend yield %
—

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

Notizie